MDXG
MiMedx Group, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-25
Figures on this page computed 2026-11-08 12:12 UTC
Last close
3.20USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-25
10.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-25
41.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
11.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
17.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
0.09Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth11.0%56 of 100, above its sector
- Returns on capital41.5%92 of 100, above its sector
- Margins82.6%82 of 100, above its sector
- Price10.0x72 of 100, above its sector
- Safety0.0983 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-25
- Sales1.36x
Its own average over 10 years, 307.2M.
- Profit7.04x
Its own average over 10 years, 6.9M.
- Free cash flow4.45x
Its own average over 10 years, 16.4M.
- Debt0.55x
Its own average over 8 years, 40.8M.
- Price0.47x
Its own average over 11 years, 7. Market data, 2026-11-04
Profit is furthest from its own average, at 7.04 times.
Sales is 1.36 times its own 10-year average; Profit is 7.04 times its own 10-year average; Free cash flow is 4.45 times its own 10-year average; Debt is 0.55 times its own 8-year average; Price is 0.47 times its own 11-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-25
Sales against its own 10-year average1.36
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Profit against its own 10-year average7.04
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Free cash flow against its own 10-year average4.45
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Debt against its own 8-year average0.55
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Price against its own 11-year average0.47Market data, 2026-11-04
- Source
- market
- Taken on
- 2026-11-04
- Reported in
- USD